Skip to main content

Table 2 The association between SLC2A3 protein levels and the clinicopathological parameters in 40 GC patients included in the DFS analysis

From: SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer

Clinicopathological parameters

SLC2A3 expression

p-value

Low

High

Age

 < 60

8

10

p = 0.422

 ≥ 60

8

14

 

Gender

 Male

12

18

p = 0.649

 Female

4

6

 

pStage

 I

5

2

p = 0.076

 II–IV

11

22

 

pT grade

 T1, 2

7

4

p = 0.065

 T3, 4

9

20

 

pN grade

 N0

9

10

p = 0.281

 N1–3

7

14

 

Total

16

24

 
  1. SLC2A3 protein expression was showed no association with age, gender, pathological stage, and TNM grades
  2. GC Gastric cancer, OS overall survival, TNM tumor, N lymph node, M metastasis